Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04896229 · ClinicalTrials.gov registry record · NA

Talk STEM Familia: Dual-Language (TSFII)

A NA study, sponsored by Oregon Research Behavioral Intervention Strategies.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT04896229: Completed NA study, sponsored by Oregon Research Behavioral Intervention Strategies.

NCT04896229 is a NA study that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04896229, a NA study, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The study will evaluate Talk STEM Familia (TSF) effects on student and parent scientific academic vocabulary knowledge and usage, scientific academic vocabulary (SAV) learning behaviors, academic self efficacy, and satisfaction with the program, including acceptance of the technology and its usability.

Primary Outcome

AVM (Academic Vocabulary Meaning) will measure change in student vocabulary knowledge (multiple choice test of meaning). The multiple choice test is based on the assessment used in Beck et al. (1982) and McKeown et al. (1983) with middle school students. Scores were computed as the total percentage of vocabulary words correctly identified out of 72. Score could range from 0 to 100 and higher scores indicate greater levels of vocabulary knowledge.

Interventions

  • OTHER Talk STEM Familia Treatment Condition

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-02-01
Est. Completion 2024-09-12
Phase NA

What the finished NCT04896229 record still lists

NCT04896229 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 1 intervention - of which Talk STEM Familia Treatment Condition is the first listed.

NCT04896229 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04896229 about?

NCT04896229 is a clinical study titled "Talk STEM Familia: Dual-Language (TSFII)". The study will evaluate Talk STEM Familia (TSF) effects on student and parent scientific academic vocabulary knowledge and usage, scientific academic vocabulary (SAV) learning behaviors, academic self efficacy, and satisfaction with the program, including acceptance of the technology and its usabili...

What is the current status of trial NCT04896229?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2021-02-01. Estimated completion is 2024-09-12.

What interventions are being tested in trial NCT04896229?

The interventions under investigation include: Talk STEM Familia Treatment Condition (OTHER).

Who is sponsoring clinical trial NCT04896229?

This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04896229's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04896229, the US trial registry maintained by the National Library of Medicine. NCT04896229 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.